Eunhee Ohgami | CEO
NeuroCores, Inc.

Eunhee Ohgami is a visionary leader in the field of rare diseases and orphan drugs in pediatric neurology space, currently serving as the CEO of NeuroCores Inc. With a strong background in biotechnology and a passion for improving the lives of patients with rare diseases, Eunhee has dedicated her career to driving innovation and advancing cutting-edge therapies in the healthcare industry.

Throughout her career, Eunhee has demonstrated a unique ability to bridge the gap between science and business, leveraging her expertise to bring novel treatments to market and address unmet medical needs in the CNS area. Her strategic mindset and entrepreneurial spirit have positioned NeuroCores Inc as a key player in the orphan drug space, with a focus on developing innovative first-in- class therapies for rare pediatric neurological disorders.

As a speaker at the World Orphan Drug Congress USA 2025, Eunhee will share her insights on the future trends of orphan drug research and development. Attendees can expect to gain valuable knowledge from her expertise in navigating the complexities of the rare disease landscape and her innovative approaches to drug development.